
Ocular Drug Excipient - Global and China Top Players Market Share and Ranking 2025
The report classifies the business vertical into various segments based on components, voltage, end-user scope, and regional division. A thorough analysis of each segment with respect to their market share, growth rate, and revenue contribution forms a major part of the study.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Ocular Drug Excipient Market Overview
Excipients are important part of the drug development process and ensure that the formulation remains stable throughout the development process as well when it is administered. It is basically any other component of the drug outside the medicinal component as it acts as a vehicle or a carrier for the medicinal product. This way stability to the formulation is provided. Wrong selection of excipient can lead to complications like intoxication of the patients. In ocular drugs, they play an important role in maintaining the tonicity, pH, stability, viscosity and sterility of the formulation.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report studies and analyses global Ocular Drug Excipient status and future trends, helping the client to determine the Ocular Drug Excipient market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Ocular Drug Excipient. It provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2025 as the base year. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments. To assess the competitive environment within the market, including supplier revenue, market share, and company profiles.
Ocular Drug Excipient Market Key Takeaways
(1) Global Ocular Drug Excipient market size, history data 2020-2025 , and forecast data 2025 -2031, (US$ million) & (K Units)
(2) Global Ocular Drug Excipient sales, revenue, price by company, market share, and industry ranking 2020-2025, (US$ million) & (K Units)
(3) China Ocular Drug Excipient sales, revenue, price by company, market share, and industry ranking 2020-2025, (US$ million) & (K Units)
(4) Global Ocular Drug Excipient key consuming regions, consumption quantity, consumption value, and demand structure
(5) Global Ocular Drug Excipient key producing regions, capacity, production, and year-over-year growth
(6) Ocular Drug Excipient industry chains, upstream, midstream, and downstream
Ocular Drug Excipient Market: Key Players
The competitive landscape of the Ocular Drug Excipient Market offers a comprehensive analysis of key players. It includes insights such as company overviews, financial performance, revenue generation, market potential, research and development investments, new market strategies, regional presence, strengths and weaknesses, product launches, product range, and application leadership. These data points specifically pertain to the companies' activities and focus within the Ocular Drug Excipient Market. Some of the major players operating in the Ocular Drug Excipient Market are:
- BASF
- Beneo
- Evonik
- Excipact
- Fuji Chemical Industries
- InVitria
- Innophos
- JRS Pharma
- IOI Oleochemical
- Millipore Sigma
- Mallinckrodt Pharmaceuticals
- Pfanstiehl
- PerkinElmer
- Natoli
- DFE Pharma
Market IntelliX's study on the Ocular Drug Excipient market offers information divided into important segments — type, applications, end-use, and region. This report provides comprehensive data and information about the important market dynamics and growth parameters associated with these categories.
Ocular Drug Excipient Market by Type [Analysis by Value from 2020 to 2031]:
- Organic Compounds
- Inorganic Compounds
Ocular Drug Excipient Market by Application [Analysis by Value from 2020 to 2031]:
- Pharmaceutical Companies
- Biopharmaceutical Companies
- Contract Manufacturing Organizations (CMOs)
- Others
Ocular Drug Excipient Market by Region [Analysis by Value from 2020 to 2031]:
- North America (United States, Canada, and Mexico)
- Europe (UK, Germany, France, Russia, and Italy)
- Asia-Pacific (China, Korea, Japan, India, and Southeast Asia)
- South America (Brazil, Colombia, Argentina, etc.)
- The Middle East and Africa (Saudi Arabia, UAE, Nigeria, Egypt, and South Africa)
Ocular Drug Excipient Market Report Includes:
Chapter 1: To describe Ocular Drug Excipient product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Ocular Drug Excipient market share and ranking of major manufacturers, sales quantity, revenue, average price, 2020-2025
Chapter 3: China Ocular Drug Excipient market share and ranking of major manufacturers, sales quantity, revenue, average price, 2020-2025
Chapter 4: Global key producing regions of Ocular Drug Excipient , percent & CAGR, 2020 - 2031
Chapter 5: Ocular Drug Excipient industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2020 - 2031
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2020 - 2031
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2020 - 2031
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2020 - 2031
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, and gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Ocular Drug Excipient Definition
1.2 Global Ocular Drug Excipient Market Size and Forecast
1.2.1 By Consumption Value, Global Ocular Drug Excipient Market Size, 2020-2031
1.2.2 By Sales Quantity, Global Ocular Drug Excipient Market Size, 2020-2031
1.2.3 Global Ocular Drug Excipient Average Selling Price (ASP), 2020-2031
1.3 China Ocular Drug Excipient Market Size and Forecast
1.3.1 By Consumption Value, China Ocular Drug Excipient Market Size, 2020-2031
1.3.2 By Sales Quantity, China Ocular Drug Excipient Market Size, 2020-2031
1.3.3 China Ocular Drug Excipient Average Selling Price (ASP), 2020-2031
1.4 Share of China Ocular Drug Excipient Market with Respect to the Global Market
1.4.1 By Consumption Value, China Ocular Drug Excipient Market Share in Global, 2020-2031
1.4.2 By Sales Quantity, China Ocular Drug Excipient Market Share in Global, 2020-2031
1.4.3 Ocular Drug Excipient Market Size: China VS Global, 2020-2031
1.5 Ocular Drug Excipient Market Dynamics
1.5.1 Ocular Drug Excipient Market Drivers
1.5.2 Ocular Drug Excipient Market Restraints
1.5.3 Ocular Drug Excipient Industry Trends
1.5.4 Ocular Drug Excipient Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Ocular Drug Excipient, Global Market Share by Company, 2020-2025
2.2 By Sales Quantity of Ocular Drug Excipient, Global Market Share by Company, 2020-2025
2.3 Ocular Drug Excipient Average Selling Price (ASP) by Company, 2020-2025
2.4 Global Ocular Drug Excipient Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Ocular Drug Excipient Concentration Ratio
2.6 Global Ocular Drug Excipient Mergers & Acquisitions, Expansion Plans
2.7 Global Ocular Drug Excipient Manufacturers Product Type
2.8 Head Office and Ocular Drug Excipient Production Site of Key Manufacturer
2.9 Ocular Drug Excipient Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Ocular Drug Excipient, China Market Share by Company, 2020-2025
3.2 By Sales Quantity of Ocular Drug Excipient, China Market Share by Company, 2020-2025
3.3 China Ocular Drug Excipient Ocular Drug Excipient Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Ocular Drug Excipient Capacity, Output and Capacity Utilization, 2020-2031
4.2 Global Ocular Drug Excipient Capacity by Region
4.3 Global Ocular Drug Excipient Production & Forecast by Region, 2020 VS 2024 VS 2031
4.4 Global Ocular Drug Excipient Production by Region, 2020-2031
4.5 Global Ocular Drug Excipient Production Market Share & Forecast by Region, 2020-2031
5 Industry Chain Analysis
5.1 Ocular Drug Excipient Industry Chain
5.2 Ocular Drug Excipient Upstream Analysis
5.2.1 Ocular Drug Excipient Core Raw Materials
5.2.2 Main Manufacturers of Ocular Drug Excipient Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Ocular Drug Excipient Production Mode
5.6 Ocular Drug Excipient Procurement Model
5.7 Ocular Drug Excipient Industry Sales Model and Sales Channels
5.7.1 Ocular Drug Excipient Sales Model
5.7.2 Ocular Drug Excipient Typical Distributors
6 Sights by Product Type
6.1 Ocular Drug Excipient Classification
6.1.1 Organic Compounds
6.1.2 Inorganic Compounds
6.2 by Type, Global Ocular Drug Excipient Consumption Value & CAGR, 2020 VS 2024 VS 2031
6.3 by Type, Global Ocular Drug Excipient Consumption Value, 2020-2031
6.4 by Type, Global Ocular Drug Excipient Sales Quantity, 2020-2031
6.5 by Type, Global Ocular Drug Excipient Average Selling Price (ASP), 2020-2031
7 Sights by Application
7.1 Ocular Drug Excipient Segment by Application
7.1.1 Pharmaceutical Companies
7.1.2 Biopharmaceutical Companies
7.1.3 Contract Manufacturing Organizations (CMOs)
7.1.4 Others
7.2 by Application, Global Ocular Drug Excipient Consumption Value & CAGR, 2020 VS 2024 VS 2031
7.3 by Application, Global Ocular Drug Excipient Consumption Value, 2020-2031
7.4 by Application, Global Ocular Drug Excipient Sales Quantity, 2020-2031
7.5 by Application, Global Ocular Drug Excipient Price, 2020-2031
8 Sales Sights by Region
8.1 By Region, Global Ocular Drug Excipient Consumption Value, 2020 VS 2024 VS 2031
8.2 By Region, Global Ocular Drug Excipient Consumption Value, 2020-2031
8.3 By Region, Global Ocular Drug Excipient Sales Quantity, 2020-2031
8.4 North America
8.4.1 North America Ocular Drug Excipient Market Size & Forecasts, 2020-2031
8.4.2 By Country, North America Ocular Drug Excipient Market Size Market Share
8.5 Europe
8.5.1 Europe Ocular Drug Excipient Market Size & Forecasts, 2020-2031
8.5.2 By Country, Europe Ocular Drug Excipient Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Ocular Drug Excipient Market Size & Forecasts, 2020-2031
8.6.2 By Country/Region, Asia Pacific Ocular Drug Excipient Market Size Market Share
8.7 South America
8.7.1 South America Ocular Drug Excipient Market Size & Forecasts, 2020-2031
8.7.2 By Country, South America Ocular Drug Excipient Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Ocular Drug Excipient Market Size & CAGR, 2020 VS 2024 VS 2031
9.2 By Country, Global Ocular Drug Excipient Consumption Value, 2020-2031
9.3 By Country, Global Ocular Drug Excipient Sales Quantity, 2020-2031
9.4 United States
9.4.1 United States Ocular Drug Excipient Market Size, 2020-2031
9.4.2 by Type, United States Ocular Drug Excipient Sales Quantity Market Share, 2024 VS 2031
9.4.3 by Application, United States Ocular Drug Excipient Sales Quantity Market Share, 2024 VS 2031
9.5 Europe
9.5.1 Europe Ocular Drug Excipient Market Size, 2020-2031
9.5.2 by Type, Europe Ocular Drug Excipient Sales Quantity Market Share, 2024 VS 2031
9.5.3 by Application, Europe Ocular Drug Excipient Sales Quantity Market Share, 2024 VS 2031
9.6 China
9.6.1 China Ocular Drug Excipient Market Size, 2020-2031
9.6.2 by Type, China Ocular Drug Excipient Sales Quantity Market Share, 2024 VS 2031
9.6.3 by Application, China Ocular Drug Excipient Sales Quantity Market Share, 2024 VS 2031
9.7 Japan
9.7.1 Japan Ocular Drug Excipient Market Size, 2020-2031
9.7.2 by Type, Japan Ocular Drug Excipient Sales Quantity Market Share, 2024 VS 2031
9.7.3 by Application, Japan Ocular Drug Excipient Sales Quantity Market Share, 2024 VS 2031
9.8 South Korea
9.8.1 South Korea Ocular Drug Excipient Market Size, 2020-2031
9.8.2 by Type, South Korea Ocular Drug Excipient Sales Quantity Market Share, 2024 VS 2031
9.8.3 by Application, South Korea Ocular Drug Excipient Sales Quantity Market Share, 2024 VS 2031
9.9 Southeast Asia
9.9.1 Southeast Asia Ocular Drug Excipient Market Size, 2020-2031
9.9.2 by Type, Southeast Asia Ocular Drug Excipient Sales Quantity Market Share, 2024 VS 2031
9.9.3 by Application, Southeast Asia Ocular Drug Excipient Sales Quantity Market Share, 2024 VS 2031
9.10 India
9.10.1 India Ocular Drug Excipient Market Size, 2020-2031
9.10.2 by Type, India Ocular Drug Excipient Sales Quantity Market Share, 2024 VS 2031
9.10.3 by Application, India Ocular Drug Excipient Sales Quantity Market Share, 2024 VS 2031
9.11 Middle East & Africa
9.11.1 Middle East & Africa Ocular Drug Excipient Market Size, 2020-2031
9.11.2 by Type, Middle East & Africa Ocular Drug Excipient Sales Quantity Market Share, 2024 VS 2031
9.11.3 by Application, Middle East & Africa Ocular Drug Excipient Sales Quantity Market Share, 2024 VS 2031
10 Manufacturers Profile
10.1 BASF
10.1.1 BASF Company Information, Head Office, Market Area, and Industry Position
10.1.2 BASF Ocular Drug Excipient Models, Specifications, and Application
10.1.3 BASF Ocular Drug Excipient Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.1.4 BASF Company Profile and Main Business
10.1.5 BASF Recent Developments
10.2 Beneo
10.2.1 Beneo Company Information, Head Office, Market Area, and Industry Position
10.2.2 Beneo Ocular Drug Excipient Models, Specifications, and Application
10.2.3 Beneo Ocular Drug Excipient Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.2.4 Beneo Company Profile and Main Business
10.2.5 Beneo Recent Developments
10.3 Evonik
10.3.1 Evonik Company Information, Head Office, Market Area, and Industry Position
10.3.2 Evonik Ocular Drug Excipient Models, Specifications, and Application
10.3.3 Evonik Ocular Drug Excipient Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.3.4 Evonik Company Profile and Main Business
10.3.5 Evonik Recent Developments
10.4 Excipact
10.4.1 Excipact Company Information, Head Office, Market Area, and Industry Position
10.4.2 Excipact Ocular Drug Excipient Models, Specifications, and Application
10.4.3 Excipact Ocular Drug Excipient Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.4.4 Excipact Company Profile and Main Business
10.4.5 Excipact Recent Developments
10.5 Fuji Chemical Industries
10.5.1 Fuji Chemical Industries Company Information, Head Office, Market Area, and Industry Position
10.5.2 Fuji Chemical Industries Ocular Drug Excipient Models, Specifications, and Application
10.5.3 Fuji Chemical Industries Ocular Drug Excipient Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.5.4 Fuji Chemical Industries Company Profile and Main Business
10.5.5 Fuji Chemical Industries Recent Developments
10.6 InVitria
10.6.1 InVitria Company Information, Head Office, Market Area, and Industry Position
10.6.2 InVitria Ocular Drug Excipient Models, Specifications, and Application
10.6.3 InVitria Ocular Drug Excipient Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.6.4 InVitria Company Profile and Main Business
10.6.5 InVitria Recent Developments
10.7 Innophos
10.7.1 Innophos Company Information, Head Office, Market Area, and Industry Position
10.7.2 Innophos Ocular Drug Excipient Models, Specifications, and Application
10.7.3 Innophos Ocular Drug Excipient Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.7.4 Innophos Company Profile and Main Business
10.7.5 Innophos Recent Developments
10.8 JRS Pharma
10.8.1 JRS Pharma Company Information, Head Office, Market Area, and Industry Position
10.8.2 JRS Pharma Ocular Drug Excipient Models, Specifications, and Application
10.8.3 JRS Pharma Ocular Drug Excipient Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.8.4 JRS Pharma Company Profile and Main Business
10.8.5 JRS Pharma Recent Developments
10.9 IOI Oleochemical
10.9.1 IOI Oleochemical Company Information, Head Office, Market Area, and Industry Position
10.9.2 IOI Oleochemical Ocular Drug Excipient Models, Specifications, and Application
10.9.3 IOI Oleochemical Ocular Drug Excipient Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.9.4 IOI Oleochemical Company Profile and Main Business
10.9.5 IOI Oleochemical Recent Developments
10.10 Millipore Sigma
10.10.1 Millipore Sigma Company Information, Head Office, Market Area, and Industry Position
10.10.2 Millipore Sigma Ocular Drug Excipient Models, Specifications, and Application
10.10.3 Millipore Sigma Ocular Drug Excipient Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.10.4 Millipore Sigma Company Profile and Main Business
10.10.5 Millipore Sigma Recent Developments
10.11 Mallinckrodt Pharmaceuticals
10.11.1 Mallinckrodt Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
10.11.2 Mallinckrodt Pharmaceuticals Ocular Drug Excipient Models, Specifications, and Application
10.11.3 Mallinckrodt Pharmaceuticals Ocular Drug Excipient Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.11.4 Mallinckrodt Pharmaceuticals Company Profile and Main Business
10.11.5 Mallinckrodt Pharmaceuticals Recent Developments
10.12 Pfanstiehl
10.12.1 Pfanstiehl Company Information, Head Office, Market Area, and Industry Position
10.12.2 Pfanstiehl Ocular Drug Excipient Models, Specifications, and Application
10.12.3 Pfanstiehl Ocular Drug Excipient Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.12.4 Pfanstiehl Company Profile and Main Business
10.12.5 Pfanstiehl Recent Developments
10.13 PerkinElmer
10.13.1 PerkinElmer Company Information, Head Office, Market Area, and Industry Position
10.13.2 PerkinElmer Ocular Drug Excipient Models, Specifications, and Application
10.13.3 PerkinElmer Ocular Drug Excipient Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.13.4 PerkinElmer Company Profile and Main Business
10.13.5 PerkinElmer Recent Developments
10.14 Natoli
10.14.1 Natoli Company Information, Head Office, Market Area, and Industry Position
10.14.2 Natoli Ocular Drug Excipient Models, Specifications, and Application
10.14.3 Natoli Ocular Drug Excipient Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.14.4 Natoli Company Profile and Main Business
10.14.5 Natoli Recent Developments
10.15 DFE Pharma
10.15.1 DFE Pharma Company Information, Head Office, Market Area, and Industry Position
10.15.2 DFE Pharma Ocular Drug Excipient Models, Specifications, and Application
10.15.3 DFE Pharma Ocular Drug Excipient Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.15.4 DFE Pharma Company Profile and Main Business
10.15.5 DFE Pharma Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Tables & Figures:
List of Tables
Table 1. Ocular Drug Excipient Consumption Value & CAGR: China VS Global, 2020-2031, US$ Million
Table 2. Ocular Drug Excipient Market Restraints
Table 3. Ocular Drug Excipient Market Trends
Table 4. Ocular Drug Excipient Industry Policy
Table 5. Global Ocular Drug Excipient Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024
Table 6. Global Ocular Drug Excipient Revenue Share by Company, 2020-2025, Ranked by Data of 2024
Table 7. Global Ocular Drug Excipient Sales Quantity by Company, (2020-2025) & (Kiloton), Ranked Based on Sales in 2024
Table 8. Global Ocular Drug Excipient Sales Quantity by Company, 2020-2025, Ranked by Data of 2024
Table 9. Global Ocular Drug Excipient Average Selling Price (ASP) by Company, (2020-2025) & (US$/Ton)
Table 10. Global Ocular Drug Excipient Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Ocular Drug Excipient Mergers & Acquisitions, Expansion Plans
Table 12. Global Ocular Drug Excipient Manufacturers Product Type
Table 13. Head Office and Ocular Drug Excipient Production Site of Key Manufacturer
Table 14. Ocular Drug Excipient Capacity of Major Manufacturers and Future Plan
Table 15. China Ocular Drug Excipient Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024
Table 16. China Ocular Drug Excipient Revenue Share by Company, 2020-2025, Ranked by Data of 2024
Table 17. China Ocular Drug Excipient Sales Quantity by Company, (2020-2025) & (Kiloton), Ranked Based on Sales in 2024
Table 18. China Ocular Drug Excipient Sales Quantity by Company, 2020-2025, Ranked by Data of 2024
Table 19. Global Ocular Drug Excipient Production & Forecast by Region, 2020 VS 2024 VS 2031, (Kiloton)
Table 20. Global Ocular Drug Excipient Production by Region, 2020-2025, (Kiloton)
Table 21. Global Ocular Drug Excipient Production Forecast by Region, 2026-2031, (Kiloton)
Table 22. Global Key Players of Ocular Drug Excipient Upstream (Raw Materials)
Table 23. Global Ocular Drug Excipient Typical Customers
Table 24. Ocular Drug Excipient Typical Distributors
Table 25. by Type, Global Ocular Drug Excipient Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million
Table 26. by Application, Global Ocular Drug Excipient Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million
Table 27. By Region, Global Ocular Drug Excipient Consumption Value, 2020 VS 2024 VS 2031, US$ Million
Table 28. By Region, Global Ocular Drug Excipient Consumption Value, 2020-2031, US$ Million
Table 29. By Region, Global Ocular Drug Excipient Sales Quantity, 2020-2031, (Kiloton)
Table 30. By Country, Global Ocular Drug Excipient Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million
Table 31. By Country, Global Ocular Drug Excipient Consumption Value, 2020-2031, US$ Million
Table 32. By Country, Global Ocular Drug Excipient Consumption Value Market Share, 2020-2031
Table 33. By Country, Global Ocular Drug Excipient Sales Quantity, 2020-2031, (Kiloton)
Table 34. By Country, Global Ocular Drug Excipient Sales Quantity Market Share, 2020-2031
Table 35. BASF Company Information, Head Office, Market Area, and Industry Position
Table 36. BASF Ocular Drug Excipient Models, Specifications, and Application
Table 37. BASF Ocular Drug Excipient Sales Quantity (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2020-2025
Table 38. BASF Company Profile and Main Business
Table 39. BASF Recent Developments
Table 40. Beneo Company Information, Head Office, Market Area, and Industry Position
Table 41. Beneo Ocular Drug Excipient Models, Specifications, and Application
Table 42. Beneo Ocular Drug Excipient Sales Quantity (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2020-2025
Table 43. Beneo Company Profile and Main Business
Table 44. Beneo Recent Developments
Table 45. Evonik Company Information, Head Office, Market Area, and Industry Position
Table 46. Evonik Ocular Drug Excipient Models, Specifications, and Application
Table 47. Evonik Ocular Drug Excipient Sales Quantity (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2020-2025
Table 48. Evonik Company Profile and Main Business
Table 49. Evonik Recent Developments
Table 50. Excipact Company Information, Head Office, Market Area, and Industry Position
Table 51. Excipact Ocular Drug Excipient Models, Specifications, and Application
Table 52. Excipact Ocular Drug Excipient Sales Quantity (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2020-2025
Table 53. Excipact Company Profile and Main Business
Table 54. Excipact Recent Developments
Table 55. Fuji Chemical Industries Company Information, Head Office, Market Area, and Industry Position
Table 56. Fuji Chemical Industries Ocular Drug Excipient Models, Specifications, and Application
Table 57. Fuji Chemical Industries Ocular Drug Excipient Sales Quantity (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2020-2025
Table 58. Fuji Chemical Industries Company Profile and Main Business
Table 59. Fuji Chemical Industries Recent Developments
Table 60. InVitria Company Information, Head Office, Market Area, and Industry Position
Table 61. InVitria Ocular Drug Excipient Models, Specifications, and Application
Table 62. InVitria Ocular Drug Excipient Sales Quantity (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2020-2025
Table 63. InVitria Company Profile and Main Business
Table 64. InVitria Recent Developments
Table 65. Innophos Company Information, Head Office, Market Area, and Industry Position
Table 66. Innophos Ocular Drug Excipient Models, Specifications, and Application
Table 67. Innophos Ocular Drug Excipient Sales Quantity (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2020-2025
Table 68. Innophos Company Profile and Main Business
Table 69. Innophos Recent Developments
Table 70. JRS Pharma Company Information, Head Office, Market Area, and Industry Position
Table 71. JRS Pharma Ocular Drug Excipient Models, Specifications, and Application
Table 72. JRS Pharma Ocular Drug Excipient Sales Quantity (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2020-2025
Table 73. JRS Pharma Company Profile and Main Business
Table 74. JRS Pharma Recent Developments
Table 75. IOI Oleochemical Company Information, Head Office, Market Area, and Industry Position
Table 76. IOI Oleochemical Ocular Drug Excipient Models, Specifications, and Application
Table 77. IOI Oleochemical Ocular Drug Excipient Sales Quantity (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2020-2025
Table 78. IOI Oleochemical Company Profile and Main Business
Table 79. IOI Oleochemical Recent Developments
Table 80. Millipore Sigma Company Information, Head Office, Market Area, and Industry Position
Table 81. Millipore Sigma Ocular Drug Excipient Models, Specifications, and Application
Table 82. Millipore Sigma Ocular Drug Excipient Sales Quantity (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2020-2025
Table 83. Millipore Sigma Company Profile and Main Business
Table 84. Millipore Sigma Recent Developments
Table 85. Mallinckrodt Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
Table 86. Mallinckrodt Pharmaceuticals Ocular Drug Excipient Models, Specifications, and Application
Table 87. Mallinckrodt Pharmaceuticals Ocular Drug Excipient Sales Quantity (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2020-2025
Table 88. Mallinckrodt Pharmaceuticals Company Profile and Main Business
Table 89. Mallinckrodt Pharmaceuticals Recent Developments
Table 90. Pfanstiehl Company Information, Head Office, Market Area, and Industry Position
Table 91. Pfanstiehl Ocular Drug Excipient Models, Specifications, and Application
Table 92. Pfanstiehl Ocular Drug Excipient Sales Quantity (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2020-2025
Table 93. Pfanstiehl Company Profile and Main Business
Table 94. Pfanstiehl Recent Developments
Table 95. PerkinElmer Company Information, Head Office, Market Area, and Industry Position
Table 96. PerkinElmer Ocular Drug Excipient Models, Specifications, and Application
Table 97. PerkinElmer Ocular Drug Excipient Sales Quantity (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2020-2025
Table 98. PerkinElmer Company Profile and Main Business
Table 99. PerkinElmer Recent Developments
Table 100. Natoli Company Information, Head Office, Market Area, and Industry Position
Table 101. Natoli Ocular Drug Excipient Models, Specifications, and Application
Table 102. Natoli Ocular Drug Excipient Sales Quantity (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2020-2025
Table 103. Natoli Company Profile and Main Business
Table 104. Natoli Recent Developments
Table 105. DFE Pharma Company Information, Head Office, Market Area, and Industry Position
Table 106. DFE Pharma Ocular Drug Excipient Models, Specifications, and Application
Table 107. DFE Pharma Ocular Drug Excipient Sales Quantity (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2020-2025
Table 108. DFE Pharma Company Profile and Main Business
Table 109. DFE Pharma Recent Developments
List of Figures
Figure 1. Ocular Drug Excipient Picture
Figure 2. Global Ocular Drug Excipient Consumption Value, (US$ million) & (2020-2031)
Figure 3. Global Ocular Drug Excipient Sales Quantity, (Kiloton) & (2020-2031)
Figure 4. Global Ocular Drug Excipient Average Selling Price (ASP), (2020-2031) & (US$/Ton)
Figure 5. China Ocular Drug Excipient Consumption Value, (US$ million) & (2020-2031)
Figure 6. China Ocular Drug Excipient Sales Quantity (Kiloton) & (2020-2031)
Figure 7. China Ocular Drug Excipient Average Selling Price (ASP), (US$/Ton) & (2020-2031)
Figure 8. By Consumption Value, China Ocular Drug Excipient Market Share of Global, 2020-2031
Figure 9. By Sales Quantity, China Ocular Drug Excipient Market Share of Global, 2020-2031
Figure 10. Global Ocular Drug Excipient Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2024
Figure 11. China Ocular Drug Excipient Key Participants, Market Share, 2024
Figure 12. Global Ocular Drug Excipient Capacity, Production and Capacity Utilization, 2020-2031
Figure 13. Global Ocular Drug Excipient Capacity Market Share by Region, 2024 VS 2031
Figure 14. Global Ocular Drug Excipient Production Market Share & Forecast by Region, 2020-2031
Figure 15. Ocular Drug Excipient Industry Chain
Figure 16. Ocular Drug Excipient Procurement Model
Figure 17. Ocular Drug Excipient Sales Model
Figure 18. Ocular Drug Excipient Sales Channels, Direct Sales, and Distribution
Figure 19. Organic Compounds
Figure 20. Inorganic Compounds
Figure 21. by Type, Global Ocular Drug Excipient Consumption Value, 2020-2031, US$ Million
Figure 22. by Type, Global Ocular Drug Excipient Consumption Value Market Share, 2020-2031
Figure 23. by Type, Global Ocular Drug Excipient Sales Quantity, 2020-2031, (Kiloton)
Figure 24. by Type, Global Ocular Drug Excipient Sales Quantity Market Share, 2020-2031
Figure 25. by Type, Global Ocular Drug Excipient Average Selling Price (ASP), 2020-2031, (US$/Ton)
Figure 26. Pharmaceutical Companies
Figure 27. Biopharmaceutical Companies
Figure 28. Contract Manufacturing Organizations (CMOs)
Figure 29. Others
Figure 30. by Application, Global Ocular Drug Excipient Consumption Value, 2020-2031, US$ Million
Figure 31. by Application, Global Ocular Drug Excipient Revenue Market Share, 2020-2031
Figure 32. by Application, Global Ocular Drug Excipient Sales Quantity, 2020-2031, (Kiloton)
Figure 33. by Application, Global Ocular Drug Excipient Sales Quantity Market Share, 2020-2031
Figure 34. by Application, Global Ocular Drug Excipient Price, 2020-2031, (US$/Ton)
Figure 35. By Region, Global Ocular Drug Excipient Consumption Value Market Share, 2020-2031
Figure 36. By Region, Global Ocular Drug Excipient Sales Quantity Market Share, 2020-2031
Figure 37. North America Ocular Drug Excipient Consumption Value & Forecasts, 2020-2031, US$ Million
Figure 38. By Country, North America Ocular Drug Excipient Consumption Value Market Share, 2024
Figure 39. Europe Ocular Drug Excipient Consumption Value & Forecasts, 2020-2031, US$ Million
Figure 40. By Country, Europe Ocular Drug Excipient Consumption Value Market Share, 2024
Figure 41. Asia Pacific Ocular Drug Excipient Consumption Value & Forecasts, 2020-2031, US$ Million
Figure 42. By Country/Region, Asia Pacific Ocular Drug Excipient Consumption Value Market Share, 2024
Figure 43. South America Ocular Drug Excipient Consumption Value & Forecasts, 2020-2031, US$ Million
Figure 44. By Country, South America Ocular Drug Excipient Consumption Value Market Share, 2024
Figure 45. Middle East & Africa Ocular Drug Excipient Consumption Value & Forecasts, 2020-2031, US$ Million
Figure 46. United States Ocular Drug Excipient Sales Quantity, 2020-2031, (Kiloton)
Figure 47. by Type, United States Ocular Drug Excipient Sales Quantity Market Share, 2024 VS 2031
Figure 48. by Application, United States Ocular Drug Excipient Sales Quantity Market Share, 2024 VS 2031
Figure 49. Europe Ocular Drug Excipient Sales Quantity, 2020-2031, (Kiloton)
Figure 50. by Type, Europe Ocular Drug Excipient Sales Quantity Market Share, 2024 VS 2031
Figure 51. by Application, Europe Ocular Drug Excipient Sales Quantity Market Share, 2024 VS 2031
Figure 52. China Ocular Drug Excipient Sales Quantity, 2020-2031, (Kiloton)
Figure 53. by Type, China Ocular Drug Excipient Sales Quantity Market Share, 2024 VS 2031
Figure 54. by Application, China Ocular Drug Excipient Sales Quantity Market Share, 2024 VS 2031
Figure 55. Japan Ocular Drug Excipient Sales Quantity, 2020-2031, (Kiloton)
Figure 56. by Type, Japan Ocular Drug Excipient Sales Quantity Market Share, 2024 VS 2031
Figure 57. by Application, Japan Ocular Drug Excipient Sales Quantity Market Share, 2024 VS 2031
Figure 58. South Korea Ocular Drug Excipient Sales Quantity, 2020-2031, (Kiloton)
Figure 59. by Type, South Korea Ocular Drug Excipient Sales Quantity Market Share, 2024 VS 2031
Figure 60. by Application, South Korea Ocular Drug Excipient Sales Quantity Market Share, 2024 VS 2031
Figure 61. Southeast Asia Ocular Drug Excipient Sales Quantity, 2020-2031, (Kiloton)
Figure 62. by Type, Southeast Asia Ocular Drug Excipient Sales Quantity Market Share, 2024 VS 2031
Figure 63. by Application, Southeast Asia Ocular Drug Excipient Sales Quantity Market Share, 2024 VS 2031
Figure 64. India Ocular Drug Excipient Sales Quantity, 2020-2031, (Kiloton)
Figure 65. by Type, India Ocular Drug Excipient Sales Quantity Market Share, 2024 VS 2031
Figure 66. by Application, India Ocular Drug Excipient Sales Quantity Market Share, 2024 VS 2031
Figure 67. Middle East & Africa Ocular Drug Excipient Sales Quantity, 2020-2031, (Kiloton)
Figure 68. by Type, Middle East & Africa Ocular Drug Excipient Sales Quantity Market Share, 2024 VS 2031
Figure 69. by Application, Middle East & Africa Ocular Drug Excipient Sales Quantity Market Share, 2024 VS 2031
Figure 70. Research Methodology
Figure 71. Breakdown of Primary Interviews
Figure 72. Bottom-up Approaches
Figure 73. Top-down Approaches
Research Methodology:
Ocular Drug Excipient Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|